548 related articles for article (PubMed ID: 17926641)
21. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference.
Cheng TL; Chang WW; Su IJ; Lai MD; Huang W; Lei HY; Chang WT
Biochem Biophys Res Commun; 2005 Oct; 336(3):820-30. PubMed ID: 16153600
[TBL] [Abstract][Full Text] [Related]
23. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
Xuan B; Qian Z; Hong J; Huang W
Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
[TBL] [Abstract][Full Text] [Related]
24. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
26. Differentially expressed cellular genes following HBV: potential targets of anti-HBV drugs?
Yang J; Bo XC; Yao J; Yang NM; Wang SQ
J Viral Hepat; 2005 Jul; 12(4):357-63. PubMed ID: 15985005
[TBL] [Abstract][Full Text] [Related]
27. Stable inhibition of hepatitis B virus expression and replication by expressed siRNA.
Ren GL; Bai XF; Zhang Y; Chen HM; Huang CX; Wang PZ; Li GY; Zhang Y; Lian JQ
Biochem Biophys Res Commun; 2005 Oct; 335(4):1051-9. PubMed ID: 16111658
[TBL] [Abstract][Full Text] [Related]
28. [RNA interference inhibits replication and expression of hepatitis B virus in mice].
Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):630-4. PubMed ID: 15949363
[TBL] [Abstract][Full Text] [Related]
29. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
Arbuthnot P; Carmona S; Ely A
Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
31. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.
Guo Y; Guo H; Zhang L; Xie H; Zhao X; Wang F; Li Z; Wang Y; Ma S; Tao J; Wang W; Zhou Y; Yang W; Cheng J
J Virol; 2005 Nov; 79(22):14392-403. PubMed ID: 16254373
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
33. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
34. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
Li D; Xu DZ; Choi BC; Men K; Zhang JX; Lei XY; Yan YP
J Med Virol; 2005 Jun; 76(2):203-7. PubMed ID: 15834875
[TBL] [Abstract][Full Text] [Related]
35. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
Feng B; Wei L; Chen M; Wang L
Microbiol Res; 2008; 163(4):487-92. PubMed ID: 17317127
[TBL] [Abstract][Full Text] [Related]
36. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
Alvarado-Esquivel C; de la Ascensión Carrera-Gracia M; Conde-González CJ; Juárez-Figueroa L; Ruiz-Maya L; Aguilar-Benavides S; Torres-Valenzuela A; Sablon E
J Antimicrob Chemother; 2006 Feb; 57(2):221-3. PubMed ID: 16373428
[TBL] [Abstract][Full Text] [Related]
37. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
Pollicino T; Isgrò G; Di Stefano R; Ferraro D; Maimone S; Brancatelli S; Squadrito G; Di Marco V; Craxì A; Raimondo G
Antivir Ther; 2009; 14(5):649-54. PubMed ID: 19704167
[TBL] [Abstract][Full Text] [Related]
38. [Construction of whole-genome lamivudine-resistant hepatitis B virus mutant and its replication and expression in HepG2 cells].
Sun J; Wang C; Wen SJ; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):991-3. PubMed ID: 17666334
[TBL] [Abstract][Full Text] [Related]
39. Control of HBV replication by antiviral microRNAs transferred by lentiviral vectors for potential cell and gene therapy approaches.
Kumar M; Follenzi A; Garforth S; Gupta S
Antivir Ther; 2012; 17(3):519-28. PubMed ID: 22300804
[TBL] [Abstract][Full Text] [Related]
40. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
Hosseini SY; Sabahi F; Amini-Bavil-Olyaee S; Alavian SM; Merat S
J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
